ALSUntangled #67: rituximab

Xiaoyan Li, Carmel Armon, Paul Barkhaus, Benjamin Barnes, Michael Benatar, Tulio Bertorini, Mark Bromberg, Gregory T. Carter, Jesse Crayle, Merit Cudkowicz, Mazen Dimachkie, Eva L. Feldman, Jonathan Glass, Jill Goslinga, Terry Heiman-Patterson, Sartaj Jhooty, Rachel Lichtenstein, Isaac Lund, Christopher Mcdermott, Gary PatteeKaitlyn Pierce, Dylan Ratner, Kristiana Salmon, Paul Wicks, Richard Bedlack

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)544-547
Number of pages4
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume24
Issue number5-6
DOIs
StatePublished - 2023

ASJC Scopus Subject Areas

  • Neurology
  • Clinical Neurology

Keywords

  • ALS
  • neuroinflammation
  • off-label treatment
  • rituximab

Cite this